Insurance

Insider buy of 776 AON PLC shares by director James Stavridis shows routine confidence, not market‑moving action, amid strong fundamentals and steady growth.

Oscar Health CEO sells 2.8 M shares under Rule 10(b)(5)(1) for tax compliance—no signal of weakness, still strong momentum and a low valuation.

Fidelity National Financial’s latest insider sale by EVP Peter Sadowski shows routine portfolio rebalancing, not distress, and confirms solid fundamentals and robust governance.

Yuanbao Inc’s latest insider trades reveal a routine liquidity move—COO Li Ying Dana sold 12,000 options, bought 2,000 ADS, and retained 35%+ stake—yet investors should watch market and regulatory trends for long‑term impact.

Accelerant Holdings’ June 2026 insider sale shows disciplined Rule 10(b)(5)(1) liquidity—no market shock, but a clear sign of compliant governance and strategic portfolio management.

Accelerant Holdings insider sale: CEO Jeffrey Radke sells 80k shares under a trading plan, illustrating disciplined liquidity management without impacting market value.

Michelle Gillis sold 2,247 AFG shares at $139 on June 24, 2026—a routine portfolio rebalancing amid a new buy‑back program, reinforcing AFG’s stable growth and shareholder value strategy.

Investor insight: Dhanidina Halim’s strategic sale of 9,543 shares at $418.25 highlights a planned divestment while CEO Nolan Joseph’s bulk purchase signals confidence in Fidelity National Financial’s solid fundamentals and future growth.

Progressive insider Kelly sells 7,000 shares in a bull market—why insiders trade now and what it signals for investors.

Insider sales by Accelerant Holdings’ co‑founder show routine liquidity moves at $13.20, not a warning sign, with 7 M shares still held.